Value Bridge — JERSEY SHORE UNIVERSITY MED CTR
Current $98M → Target $124M (+$25.8M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$98.3M
Current EBITDA
$124.1M
Target EBITDA
+$25.8M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.8M
Payer Mix Optimization
$14.0M
Cost to Collect Reduction
$4.7M
Clean Claim Improvement
$3.5M
Volume & Rate Growth
$23.4M
What This Means
The 7-lever model projects a 26% EBITDA uplift from $98M to $124M. The highest-impact lever is Volume & Rate Growth at $9.3M probability-weighted.
IC talking point: "We see $26M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $284M in equity value creation."